Symbols

MMSI

Merit Medical·NASDAQ

--(--)

MMSI fundamentals

MMSI Q4 2025 Earnings

Merit Medical (MMSI) released its earnings on Feb 24, 2026: revenue was 393.94M (YoY +10.92%), beat estimates; EPS was 1.04 (YoY +11.83%), beat estimates.

Revenue / YoY

393.94M

+10.92%

EPS / YoY

1.04

+11.83%

Report date

Feb 24, 2026

MMSI Earnings Call Summary for Q4,2025

Revenue Growth & Margin Expansion: Q4 2025 revenue up 11% YoY, non-GAAP operating margin 21% (138 bps YoY expansion). Full-year 2025 free cash flow $216 million, exceeding $150M guidance.
2026 Guidance: 6-8% GAAP revenue growth, non-GAAP EPS $4.01-$4.15 (5-8% growth), free cash flow $200M+.
Strategic Shifts: Divestiture of DualCap line to focus on high-margin products; Rhapsody 2026 U.S. revenue guide $7 million reflects cautious rollout.
Risks & Challenges: 2026 faces 140 bps organic growth headwind from DualCap divestiture and $15M annual tariff impact. China growth constrained by VBP in Q1 2026.

Earnings

EPS

Revenue

Revenue & Expenses

MMSI has released its 2025 Q4 earnings report, with revenue of 393.94M, reflecting a YoY change of 10.92%, and net profit of 38.01M, showing a YoY change of 35.99%. The Sankey diagram below clearly presents MMSI's revenue sources and cost distribution.

Key Indicators

Merit Medical (MMSI) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Merit Medical (MMSI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Merit Medical (MMSI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Merit Medical (MMSI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown